Four Molecular Targets Are Reshaping Targeted Radiation Therapy for Cancer
A new review maps how PSMA, SSTR, CXCR4, and FAP targets are advancing radionuclide theranostics from proven prostate cancer and ...
A new review maps how PSMA, SSTR, CXCR4, and FAP targets are advancing radionuclide theranostics from proven prostate cancer and ...
A Matters Arising letter identifies duplicated citations, phantom reference numbers, and an omitted phase III trial outcome in a prominent ...
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
A first-in-kind pilot study reports that systemic targeted alpha therapy with actinium-225 labeled PSMA was feasible, well tolerated, and showed ...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
A new review in the Journal of Advanced Research details how self-assembling delivery platforms built from peptides, polyelectrolytes and natural ...
New ahead-of-print studies in The Journal of Nuclear Medicine showcase immune-cell PET imaging, long-acting radiopharmaceutical therapies, and validated quantitative PET ...
A review examines how silica-reinforced lipid vesicles could improve targeted drug, gene, vaccine and imaging delivery while highlighting unresolved safety ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine